The goal of this study is to assess the effectiveness of psilocybin for the treatment of
Major Depressive Disorder and potential therapeutic mechanisms. Enrolled participants will
receive a single active dose of psilocybin, or a dose considered high enough to treat
depression, administered orally with accompanying psychological support.